(1)
Vrankar, M.; Stanic, K.; Jelercic, S.; Ciric, E.; Vodusek, A. L.; But-Hadzic, J. Clinical Outcomes in Stage III Non-Small Cell Lung Cancer Patients Treated With Durvalumab After Sequential or Concurrent Platinum-Based Chemoradiotherapy – Single Institute Experience. RO 2021, 55, 482-490.